Skip to main content
. 2012 Apr 6;3(3):336–344. doi: 10.18632/oncotarget.475

Figure 3. Kaplan-Meier survival estimates stratified by p-STAT3, expression determined from immunohistochemical staining, in patients with stage IV melanoma.

Figure 3

In melanoma patients stratified based by the amount of p-STAT3 expression <1% versus ≥1%, there was no significant difference in median survival time (p = 0.86; n = 63, 236, respectively).